{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:41:04Z","timestamp":1791405664835,"version":"4.3.3"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"CNRS PhD Joint Program"},{"name":"I\u2010SITE NExT Junior Talent"},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-24-CE14-7852-01"],"award-info":[{"award-number":["ANR-24-CE14-7852-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"name":"LabEx IGO"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Tumor endothelial cells (TECs) play a critical role in regulating immune responses within the tumor microenvironment (TME). However, the mechanisms by which TECs modulate immune cell population remain unclear, particularly in non-small cell lung cancer (NSCLC). Here, we investigated how NSCLC cells tweak normal endothelial cells (NECs) into TECs and the subsequent effects on immune regulation. NECs were cocultured with various NSCLC cell lines, using 2D and 3D coculture models to evaluate TEC-mediated effects on immune cells. We show that direct coculture led to significant transcriptomic, proteomic and kinomic alterations in TECs, especially in pro-inflammatory pathways. We identified a downregulation of the co-stimulatory molecule OX40L in TECs compared to NECs, suggesting impaired T-cell proliferation support. While TECs showed a limited effect on CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell activation, TECs supported CD4\n                    <jats:sup>+<\/jats:sup>\n                    T-cells polarization into Treg and Th22 subsets. Moreover, TECs also promoted M2-like macrophages polarization, thereby potentially contributing to the TME immunosuppression. State-of-the-art single-cell RNA sequencing of 3D multicellular tumor spheroids (MCTS) revealed formidable heterogeneity in the tumor cells and cancer-associated fibroblast compartments. It also unveiled distinct TEC subpopulations, including an inflammatory subset with an unfolded-protein response signature. This TEC cluster was absent in 2D-cultured NECs but present in freshly isolated and 2D-cultured TECs from NSCLC patients. Importantly, we identified a perivascular M2-like macrophage subset within MCTS that is in close contact with TECs, and is predicted to interact with them through MIF signaling. In conclusion, TECs in NSCLC tumors play a pivotal role in remodeling the TME immune landscape by promoting immune suppression. This study highlights the complex immunoregulatory functions of TECs within different in vitro models that mimic aspects of the TME. Our data may provide new insights into potential therapeutic strategies targeting TECs or regulatory signaling to improve the efficacy of immunotherapy in NSCLC.\n                  <\/jats:p>","DOI":"10.1186\/s13046-025-03576-4","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T05:05:42Z","timestamp":1764219942000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["In vitro models to mimic tumor endothelial cell-mediated immune cell reprogramming in lung adenocarcinoma"],"prefix":"10.1186","volume":"45","author":[{"given":"Morgane","family":"Krejbich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith","family":"Fresquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marine","family":"Cotinat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Isen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hortense","family":"Perdrieau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Forest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Dom\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiphaine","family":"Delaunay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hala","family":"Awada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Dochez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Roulois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Boisgerault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Redon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Blanquart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Corre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Treps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"key":"3576_CR1","doi-asserted-by":"publisher","unstructured":"Thandra KC, Barsouk A, Saginala K, Aluru JS, Barsouk A. Epidemiology of lung cancer. Wsp\u00f3\u0142czesna Onkol. 2021;25:45\u201352. https:\/\/doi.org\/10.5114\/wo.2021.103829.","DOI":"10.5114\/wo.2021.103829"},{"key":"3576_CR2","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1056\/NEJMoa1916623","volume":"383","author":"N Howlader","year":"2020","unstructured":"Howlader N, Forjaz G, Mooradian MJ, Meza R, Kong CY, Cronin KA, et al. The effect of advances in lung-cancer treatment on population mortality. N Engl J Med. 2020;383:640\u20139. https:\/\/doi.org\/10.1056\/NEJMoa1916623.","journal-title":"N Engl J Med"},{"key":"3576_CR3","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/S1470-2045(20)30641-0","volume":"22","author":"L Paz-Ares","year":"2021","unstructured":"Paz-Ares L, Ciuleanu T-E, Cobo M, Schenker M, Zurawski B, Menezes J, et al. First-line nivolumab plus ipilimumab combined with two cycles of chemotherapy in patients with non-small-cell lung cancer (CheckMate 9LA): an international, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:198\u2013211. https:\/\/doi.org\/10.1016\/S1470-2045(20)30641-0.","journal-title":"Lancet Oncol"},{"key":"3576_CR4","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","volume":"383","author":"RS Herbst","year":"2020","unstructured":"Herbst RS, Giaccone G, de Marinis F, Reinmuth N, Vergnenegre A, Barrios CH, et al. Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC. N Engl J Med. 2020;383:1328\u201339. https:\/\/doi.org\/10.1056\/NEJMoa1917346.","journal-title":"N Engl J Med"},{"key":"3576_CR5","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1016\/S0140-6736(21)00228-2","volume":"397","author":"A Sezer","year":"2021","unstructured":"Sezer A, Kilickap S, G\u00fcm\u00fc\u015f M, Bondarenko I, \u00d6zg\u00fcro\u011flu M, Gogishvili M, et al. Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial. Lancet. 2021;397:592\u2013604. https:\/\/doi.org\/10.1016\/S0140-6736(21)00228-2.","journal-title":"Lancet"},{"key":"3576_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-023-03583-4","volume":"73","author":"K Matsumoto","year":"2024","unstructured":"Matsumoto K, Shiroyama T, Tamiya M, Minami T, Kinehara Y, Tamiya A, et al. Real-world outcomes of nivolumab plus ipilimumab and pembrolizumab with platinum-based chemotherapy in advanced non-small cell lung cancer: a multicenter retrospective comparative study. Cancer Immunol Immunother. 2024;73:4. https:\/\/doi.org\/10.1007\/s00262-023-03583-4.","journal-title":"Cancer Immunol Immunother"},{"key":"3576_CR7","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1038\/s41577-022-00694-4","volume":"22","author":"J Amersfoort","year":"2022","unstructured":"Amersfoort J, Eelen G, Carmeliet P. Immunomodulation by endothelial cells - partnering up with the immune system? Nat Rev Immunol. 2022;22:576\u201388. https:\/\/doi.org\/10.1038\/s41577-022-00694-4.","journal-title":"Nat Rev Immunol"},{"key":"3576_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33052-y","volume":"13","author":"V Geldhof","year":"2022","unstructured":"Geldhof V, de Rooij LPMH, Sokol L, Amersfoort J, De Schepper M, Rohlenova K, et al. Single cell atlas identifies lipid-processing and immunomodulatory endothelial cells in healthy and malignant breast. Nat Commun. 2022;13:5511. https:\/\/doi.org\/10.1038\/s41467-022-33052-y.","journal-title":"Nat Commun"},{"key":"3576_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ccell.2019.12.001","volume":"37","author":"J Goveia","year":"2020","unstructured":"Goveia J, Rohlenova K, Taverna F, Treps L, Conradi L-C, Pircher A, Geldhof V, de Rooij LPMH, Kalucka J, Sokol L, et al. An integrated gene expression landscape profiling approach to identify lung tumor endothelial cell heterogeneity and angiogenic candidates. Cancer Cell. 2020;37:21\u2013e3613. https:\/\/doi.org\/10.1016\/j.ccell.2019.12.001.","journal-title":"Cancer Cell"},{"key":"3576_CR10","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24:1277\u201389. https:\/\/doi.org\/10.1038\/s41591-018-0096-5.","journal-title":"Nat Med"},{"key":"3576_CR11","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.202318028","volume":"15","author":"J Verhoeven","year":"2023","unstructured":"Verhoeven J, Jacobs KA, Rizzollo F, Lodi F, Hua Y, Po\u017aniak J, et al. Tumor endothelial cell autophagy is a key vascular-immune checkpoint in melanoma. EMBO Mol Med. 2023;15:e18028. https:\/\/doi.org\/10.15252\/emmm.202318028.","journal-title":"EMBO Mol Med"},{"key":"3576_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.114020","volume":"43","author":"D Houbaert","year":"2024","unstructured":"Houbaert D, Nikolakopoulos AP, Jacobs KA, Me\u00e7e O, Roels J, Shankar G, et al. An autophagy program that promotes T cell egress from the lymph node controls responses to immune checkpoint blockade. Cell Rep. 2024;43:114020. https:\/\/doi.org\/10.1016\/j.celrep.2024.114020.","journal-title":"Cell Rep"},{"key":"3576_CR13","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.ccell.2022.01.002","volume":"40","author":"A Asrir","year":"2022","unstructured":"Asrir A, Tardiveau C, Coudert J, Laffont R, Blanchard L, Bellard E, Veerman K, Bettini S, Lafouresse F, Vina E, et al. Tumor-associated high endothelial venules mediate lymphocyte entry into tumors and predict response to PD-1 plus CTLA-4 combination immunotherapy. Cancer Cell. 2022;40:318\u2013e3349. https:\/\/doi.org\/10.1016\/j.ccell.2022.01.002.","journal-title":"Cancer Cell"},{"key":"3576_CR14","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s10456-021-09792-8","volume":"24","author":"L Blanchard","year":"2021","unstructured":"Blanchard L, Girard J-P. High endothelial venules (HEVs) in immunity, inflammation and cancer. Angiogenesis. 2021;24:719\u201353. https:\/\/doi.org\/10.1007\/s10456-021-09792-8.","journal-title":"Angiogenesis"},{"key":"3576_CR15","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nri3754","volume":"14","author":"T Kambayashi","year":"2014","unstructured":"Kambayashi T, Laufer TM. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol. 2014;14:719\u201330. https:\/\/doi.org\/10.1038\/nri3754.","journal-title":"Nat Rev Immunol"},{"key":"3576_CR16","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1038\/s41568-019-0144-6","volume":"19","author":"C Saut\u00e8s-Fridman","year":"2019","unstructured":"Saut\u00e8s-Fridman C, Petitprez F, Calderaro J, Fridman WH. Tertiary lymphoid structures in the era of cancer immunotherapy. Nat Rev Cancer. 2019;19:307\u201325. https:\/\/doi.org\/10.1038\/s41568-019-0144-6.","journal-title":"Nat Rev Cancer"},{"key":"3576_CR17","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1158\/0008-5472.CAN-19-1527","volume":"80","author":"D Leonetti","year":"2020","unstructured":"Leonetti D, Est\u00e9phan H, Ripoche N, Dubois N, Aguesse A, Gouard S, et al. Secretion of acid sphingomyelinase and ceramide by endothelial cells contributes to radiation-induced intestinal toxicity. Cancer Res. 2020;80:2651\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-19-1527.","journal-title":"Cancer Res"},{"key":"3576_CR18","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1093\/jimmun\/vkae032","volume":"214","author":"HL Smith","year":"2025","unstructured":"Smith HL, Foxall RB, Duriez PJ, Teal EL, Hoppe AD, Kanczler JM, et al. Comparison of human macrophages derived from peripheral blood and bone marrow. J Immunol. 2025;214:714\u201325. https:\/\/doi.org\/10.1093\/jimmun\/vkae032.","journal-title":"J Immunol"},{"key":"3576_CR19","doi-asserted-by":"publisher","first-page":"e12228","DOI":"10.1002\/jev2.12228","volume":"11","author":"M-S Njock","year":"2022","unstructured":"Njock M-S, O\u2019Grady T, Nivelles O, Lion M, Jacques S, Cambier M, Herkenne S, Muller F, Christian A, Remacle C, et al. Endothelial extracellular vesicles promote tumour growth by tumour-associated macrophage reprogramming. J Extracell Vesicles. 2022;11:e12228. https:\/\/doi.org\/10.1002\/jev2.12228.","journal-title":"J Extracell Vesicles"},{"key":"3576_CR20","doi-asserted-by":"publisher","first-page":"W385","DOI":"10.1093\/nar\/gkaa332","volume":"48","author":"F Taverna","year":"2020","unstructured":"Taverna F, Goveia J, Karakach TK, Khan S, Rohlenova K, Treps L, Subramanian A, Schoonjans L, Dewerchin M, Eelen G, et al. BIOMEX: an interactive workflow for (single cell) omics data interpretation and visualization. Nucleic Acids Res. 2020;48:W385\u201394. https:\/\/doi.org\/10.1093\/nar\/gkaa332.","journal-title":"Nucleic Acids Res"},{"key":"3576_CR21","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/bph.16257","volume":"181","author":"B Gy\u0151rffy","year":"2024","unstructured":"Gy\u0151rffy B. Transcriptome-level discovery of survival-associated biomarkers and therapy targets in non-small-cell lung cancer. Br J Pharmacol. 2024;181:362\u201374. https:\/\/doi.org\/10.1111\/bph.16257.","journal-title":"Br J Pharmacol"},{"key":"3576_CR22","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/nmeth.4437","volume":"14","author":"SC van den Brink","year":"2017","unstructured":"van den Brink SC, Sage F, V\u00e9rtesy \u00c1, Spanjaard B, Peterson-Maduro J, Baron CS, et al. Single-cell sequencing reveals dissociation-induced gene expression in tissue subpopulations. Nat Methods. 2017;14:935\u20136. https:\/\/doi.org\/10.1038\/nmeth.4437.","journal-title":"Nat Methods"},{"key":"3576_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan C-H, et al. Inference and analysis of cell-cell communication using cellchat. Nat Commun. 2021;12:1088. https:\/\/doi.org\/10.1038\/s41467-021-21246-9.","journal-title":"Nat Commun"},{"key":"3576_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.70707","volume":"14","author":"C Bourreau","year":"2025","unstructured":"Bourreau C, Navarro E, Cotinat M, Krejbich M, Guillonneau F, Guette C, et al. Secretomes from non-small cell lung cancer cells induce endothelial plasticity through a partial endothelial-to-mesenchymal transition. Cancer Med. 2025;14:e70707. https:\/\/doi.org\/10.1002\/cam4.70707.","journal-title":"Cancer Med"},{"key":"3576_CR25","doi-asserted-by":"publisher","DOI":"10.12688\/f1000research.124990.1","author":"G Potier","year":"2022","unstructured":"Potier G, Dom\u00e9n\u00e9 A, Paul-Gilloteaux P. A flexible open-source processing workflow for multiplexed fluorescence imaging based on cycles. F1000Res. 2022. https:\/\/doi.org\/10.12688\/f1000research.124990.1.","journal-title":"F1000Res"},{"key":"3576_CR26","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9:676\u201382. https:\/\/doi.org\/10.1038\/nmeth.2019.","journal-title":"Nat Methods"},{"key":"3576_CR27","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2023-007180","volume":"11","author":"H Komuro","year":"2023","unstructured":"Komuro H, Shinohara S, Fukushima Y, Demachi-Okamura A, Muraoka D, Masago K, et al. Single-cell sequencing on CD8\u2009+\u2009TILs revealed the nature of exhausted T cells recognizing neoantigen and cancer\/testis antigen in non-small cell lung cancer. J Immunother Cancer. 2023;11:e007180. https:\/\/doi.org\/10.1136\/jitc-2023-007180.","journal-title":"J Immunother Cancer"},{"key":"3576_CR28","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.764596","volume":"12","author":"A Frafjord","year":"2021","unstructured":"Frafjord A, Buer L, Hammarstr\u00f6m C, Aamodt H, Woldb\u00e6k PR, Brustugun OT, et al. The immune landscape of human primary lung tumors is Th2 skewed. Front Immunol. 2021;12:764596. https:\/\/doi.org\/10.3389\/fimmu.2021.764596.","journal-title":"Front Immunol"},{"key":"3576_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2020.00766","volume":"8","author":"L Nagl","year":"2020","unstructured":"Nagl L, Horvath L, Pircher A, Wolf D. Tumor endothelial cells (TECs) as potential immune directors of the tumor microenvironment - new findings and future perspectives. Front Cell Dev Biol. 2020;8:766. https:\/\/doi.org\/10.3389\/fcell.2020.00766.","journal-title":"Front Cell Dev Biol"},{"key":"3576_CR30","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1093\/intimm\/dxh255","volume":"17","author":"J Mestas","year":"2005","unstructured":"Mestas J, Crampton SP, Hori T, Hughes CCW. Endothelial cell co-stimulation through OX40 augments and prolongs T cell cytokine synthesis by stabilization of cytokine mRNA. Int Immunol. 2005;17:737\u201347. https:\/\/doi.org\/10.1093\/intimm\/dxh255.","journal-title":"Int Immunol"},{"key":"3576_CR31","doi-asserted-by":"publisher","first-page":"5014","DOI":"10.4049\/jimmunol.179.8.5014","volume":"179","author":"P Soroosh","year":"2007","unstructured":"Soroosh P, Ine S, Sugamura K, Ishii N. Differential requirements for OX40 signals on generation of effector and central memory CD4\u2009+\u2009T cells. J Immunol. 2007;179:5014\u201323. https:\/\/doi.org\/10.4049\/jimmunol.179.8.5014.","journal-title":"J Immunol"},{"key":"3576_CR32","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.jaci.2012.03.032","volume":"130","author":"R Sibilano","year":"2012","unstructured":"Sibilano R, Frossi B, Suzuki R, D\u2019Inc\u00e0 F, Gri G, Piconese S, Colombo MP, Rivera J, Pucillo CE. Modulation of Fc\u03b5RI-dependent mast cell response by OX40L via Fyn, PI3K, and RhoA. J Allergy Clin Immunol. 2012;130:751\u2013e7602. https:\/\/doi.org\/10.1016\/j.jaci.2012.03.032.","journal-title":"J Allergy Clin Immunol"},{"key":"3576_CR33","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2000567","volume":"3","author":"K Arima","year":"2010","unstructured":"Arima K, Watanabe N, Hanabuchi S, Chang M, Sun S-C, Liu Y-J. Distinct signal codes generate dendritic cell functional plasticity. Sci Signal. 2010;3:ra4. https:\/\/doi.org\/10.1126\/scisignal.2000567.","journal-title":"Sci Signal"},{"key":"3576_CR34","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1177\/1753425915586075","volume":"21","author":"J Toubiana","year":"2015","unstructured":"Toubiana J, Rossi A-L, Belaidouni N, Grimaldi D, Pene F, Chafey P, et al. Src-family-tyrosine kinase Lyn is critical for TLR2-mediated NF-\u03baB activation through the PI 3-kinase signaling pathway. Innate Immun. 2015;21:685\u201397. https:\/\/doi.org\/10.1177\/1753425915586075.","journal-title":"Innate Immun"},{"key":"3576_CR35","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1093\/intimm\/7.11.1851","volume":"7","author":"N Hohashi","year":"1995","unstructured":"Hohashi N, Hayashi T, Fusaki N, Takeuchi M, Higurashi M, Okamoto T, et al. The protein tyrosine kinase Fyn activates transcription from the HIV promoter via activation of NFkB-like DNA-binding proteins. Int Immunol. 1995;7:1851\u20139. https:\/\/doi.org\/10.1093\/intimm\/7.11.1851.","journal-title":"Int Immunol"},{"key":"3576_CR36","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1038\/ni.1770","volume":"10","author":"S Trifari","year":"2009","unstructured":"Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H. Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from T(H)-17, T(H)1 and T(H)2 cells. Nat Immunol. 2009;10:864\u201371. https:\/\/doi.org\/10.1038\/ni.1770.","journal-title":"Nat Immunol"},{"key":"3576_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/imr.12027","volume":"252","author":"S Rutz","year":"2013","unstructured":"Rutz S, Eidenschenk C, Ouyang W. IL-22, not simply a Th17 cytokine. Immunol Rev. 2013;252:116\u201332. https:\/\/doi.org\/10.1111\/imr.12027.","journal-title":"Immunol Rev"},{"key":"3576_CR38","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/j.immuni.2012.08.024","volume":"37","author":"R Basu","year":"2012","unstructured":"Basu R, O\u2019Quinn DB, Silberger DJ, Schoeb TR, Fouser L, Ouyang W, et al. Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria. Immunity. 2012;37:1061\u201375. https:\/\/doi.org\/10.1016\/j.immuni.2012.08.024.","journal-title":"Immunity"},{"key":"3576_CR39","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1038\/s41586-022-05672-3","volume":"614","author":"M Sorin","year":"2023","unstructured":"Sorin M, Rezanejad M, Karimi E, Fiset B, Desharnais L, Perus LJM, et al. Single-cell spatial landscapes of the lung tumour immune microenvironment. Nature. 2023;614:548\u201354. https:\/\/doi.org\/10.1038\/s41586-022-05672-3.","journal-title":"Nature"},{"key":"3576_CR40","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2024.2377830","volume":"13","author":"C Chatelain","year":"2024","unstructured":"Chatelain C, Berland L, Grard M, Jouand N, Fresquet J, Nader J, et al. Interplay between oncolytic measles virus, macrophages and cancer cells induces a proinflammatory tumor microenvironment. Oncoimmunology. 2024;13:2377830. https:\/\/doi.org\/10.1080\/2162402X.2024.2377830.","journal-title":"Oncoimmunology"},{"key":"3576_CR41","doi-asserted-by":"publisher","first-page":"e000182","DOI":"10.1136\/jitc-2019-000182","volume":"8","author":"T Blondy","year":"2020","unstructured":"Blondy T, d\u2019Almeida SM, Briolay T, Tabiasco J, Meiller C, Ch\u00e9n\u00e9 A-L, Cellerin L, Deshayes S, Delneste Y, Fonteneau J-F, et al. Involvement of the M-CSF\/IL-34\/CSF-1R pathway in malignant pleural mesothelioma. J Immunother Cancer. 2020;8:e000182. https:\/\/doi.org\/10.1136\/jitc-2019-000182.","journal-title":"J Immunother Cancer"},{"key":"3576_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-024-02791-5","volume":"25","author":"P Hulo","year":"2024","unstructured":"Hulo P, Deshayes S, Fresquet J, Ch\u00e9n\u00e9 A-L, Blandin S, Boisgerault N, et al. Use of non-small cell lung cancer multicellular tumor spheroids to study the impact of chemotherapy. Respir Res. 2024;25:156. https:\/\/doi.org\/10.1186\/s12931-024-02791-5.","journal-title":"Respir Res"},{"key":"3576_CR43","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/424870a","volume":"424","author":"A Abbott","year":"2003","unstructured":"Abbott A. Cell culture: biology\u2019s new dimension. Nature. 2003;424:870\u20132. https:\/\/doi.org\/10.1038\/424870a.","journal-title":"Nature"},{"key":"3576_CR44","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1096\/fj.01-1011fje","volume":"16","author":"OC Velazquez","year":"2002","unstructured":"Velazquez OC, Snyder R, Liu Z-J, Fairman RM, Herlyn M. Fibroblast-dependent differentiation of human microvascular endothelial cells into capillary-like 3-dimensional networks. FASEB J. 2002;16:1316\u20138. https:\/\/doi.org\/10.1096\/fj.01-1011fje.","journal-title":"FASEB J"},{"key":"3576_CR45","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73680-6","volume":"14","author":"I Fl\u00f6rkemeier","year":"2024","unstructured":"Fl\u00f6rkemeier I, Antons LK, Weimer JP, Hedemann N, Rogmans C, Kr\u00fcger S, et al. Multicellular ovarian cancer spheroids: novel 3d model to mimic tumour complexity. Sci Rep. 2024;14:23526. https:\/\/doi.org\/10.1038\/s41598-024-73680-6.","journal-title":"Sci Rep"},{"key":"3576_CR46","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.jaci.2020.02.034","volume":"146","author":"L Fischer-Riepe","year":"2020","unstructured":"Fischer-Riepe L, Daber N, Schulte-Schrepping J, De V\u00e9ras BC, Russo A, Pohlen M, Fischer J, Chasan AI, Wolf M, Ulas T, et al. CD163 expression defines specific, IRF8-dependent, immune-modulatory macrophages in the bone marrow. J Allergy Clin Immunol. 2020;146:1137\u201351. https:\/\/doi.org\/10.1016\/j.jaci.2020.02.034.","journal-title":"J Allergy Clin Immunol"},{"key":"3576_CR47","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1084\/jem.20151764","volume":"213","author":"D Langlais","year":"2016","unstructured":"Langlais D, Barreiro LB, Gros P. The macrophage IRF8\/IRF1 regulome is required for protection against infections and is associated with chronic inflammation. J Exp Med. 2016;213:585\u2013603. https:\/\/doi.org\/10.1084\/jem.20151764.","journal-title":"J Exp Med"},{"key":"3576_CR48","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-009983","volume":"12","author":"G Deng","year":"2024","unstructured":"Deng G, Wang P, Su R, Sun X, Wu Z, Huang Z, et al. SPI1\u2009+\u2009CD68\u2009+\u2009macrophages as a biomarker for gastric cancer metastasis: a rationale for combined antiangiogenic and immunotherapy strategies. J Immunother Cancer. 2024;12:e009983. https:\/\/doi.org\/10.1136\/jitc-2024-009983.","journal-title":"J Immunother Cancer"},{"key":"3576_CR49","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2024.155544","volume":"262","author":"Y Liu","year":"2024","unstructured":"Liu Y, Dong M, Jia Y, Yang D, Hui Y, Yang X. SPI1-mediated transcriptional activation of CEP55 promotes the malignant growth of triple-negative breast cancer and M2 macrophage polarization. Pathol Res Pract. 2024;262:155544. https:\/\/doi.org\/10.1016\/j.prp.2024.155544.","journal-title":"Pathol Res Pract"},{"key":"3576_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05546-4","volume":"22","author":"L Zhang","year":"2024","unstructured":"Zhang L, Ge T, Cui J. FLI-1-driven regulation of endothelial cells in human diseases. J Transl Med. 2024;22:740. https:\/\/doi.org\/10.1186\/s12967-024-05546-4.","journal-title":"J Transl Med"},{"issue":"1","key":"3576_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-11297-3","volume":"12","author":"Y Yamada","year":"2022","unstructured":"Yamada Y, Zhong Y, Miki S, Taura A, Rabbitts TH. The transcription factor complex LMO2\/TAL1 regulates branching and endothelial cell migration in sprouting angiogenesis. Sci Rep. 2022;12(1):7226. https:\/\/doi.org\/10.1038\/s41598-022-11297-3.","journal-title":"Sci Rep"},{"key":"3576_CR52","doi-asserted-by":"publisher","first-page":"16002","DOI":"10.1038\/ncomms16002","volume":"8","author":"AV Shah","year":"2017","unstructured":"Shah AV, Birdsey GM, Peghaire C, Pitulescu ME, Dufton NP, Yang Y, Weinberg I, Almagro O, Payne L, Mason L, J.C., et al. The endothelial transcription factor ERG mediates Angiopoietin-1-dependent control of Notch signalling and vascular stability. Nat Commun. 2017;8:16002. https:\/\/doi.org\/10.1038\/ncomms16002.","journal-title":"Nat Commun"},{"key":"3576_CR53","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1242\/jcs.00969","volume":"117","author":"M Lazrak","year":"2004","unstructured":"Lazrak M, Deleuze V, Noel D, Haouzi D, Chalhoub E, Dohet C, et al. The bHLH TAL-1\/SCL regulates endothelial cell migration and morphogenesis. J Cell Sci. 2004;117:1161\u201371. https:\/\/doi.org\/10.1242\/jcs.00969.","journal-title":"J Cell Sci"},{"key":"3576_CR54","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, et al. Single-cell analysis reveals fibroblast clusters linked to immunotherapy resistance in cancer. Cancer Discov. 2020;10:1330\u201351. https:\/\/doi.org\/10.1158\/2159-8290.CD-19-1384.","journal-title":"Cancer Discov"},{"key":"3576_CR55","doi-asserted-by":"publisher","first-page":"2606","DOI":"10.1158\/2159-8290.CD-21-1714","volume":"12","author":"JA Grout","year":"2022","unstructured":"Grout JA, Sirven P, Leader AM, Maskey S, Hector E, Puisieux I, et al. Spatial positioning and matrix programs of cancer-associated fibroblasts promote T-cell exclusion in human lung tumors. Cancer Discov. 2022;12:2606\u201325. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1714.","journal-title":"Cancer Discov"},{"key":"3576_CR56","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, Sirven P, Magagna I, Fuhrmann L, Bernard C, et al. Fibroblast heterogeneity and immunosuppressive environment in human breast cancer. Cancer Cell. 2018;33:463\u2013e47910. https:\/\/doi.org\/10.1016\/j.ccell.2018.01.011.","journal-title":"Cancer Cell"},{"key":"3576_CR57","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/wrr.12392","volume":"24","author":"M Noizet","year":"2016","unstructured":"Noizet M, Lagoutte E, Gratigny M, Bouschbacher M, Lazareth I, Crollius R, Darzacq H, X., and, Dugast-Darzacq C. Master regulators in primary skin fibroblast fate reprogramming in a human ex vivo model of chronic wounds. Wound Repair Regeneration. 2016;24:247\u201362. https:\/\/doi.org\/10.1111\/wrr.12392.","journal-title":"Wound Repair Regeneration"},{"key":"3576_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41401-025-01530-w","author":"C Zong","year":"2025","unstructured":"Zong C, Xu G-L, Ning M, Li J-Y, Wang X, Guo H-J, et al. PU.1\/Spi1 exacerbates ischemia-reperfusion induced acute kidney injury via upregulating Gata2 and promoting fibroblast activation. Acta Pharmacol Sin. 2025. https:\/\/doi.org\/10.1038\/s41401-025-01530-w.","journal-title":"Acta Pharmacol Sin"},{"key":"3576_CR59","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1158\/0008-5472.CAN-14-0350","volume":"75","author":"K-W Lee","year":"2015","unstructured":"Lee K-W, Yeo S-Y, Sung CO, Kim S-H. Twist1 is a key regulator of cancer-associated fibroblasts. Cancer Res. 2015;75:73\u201385. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0350.","journal-title":"Cancer Res"},{"key":"3576_CR60","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1158\/1078-0432.CCR-20-4226","volume":"27","author":"PM Galbo","year":"2021","unstructured":"Galbo PM, Zang X, Zheng D. Molecular features of cancer-associated fibroblast subtypes and their implication on cancer pathogenesis, prognosis, and immunotherapy resistance. Clin Cancer Res. 2021;27:2636\u201347. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4226.","journal-title":"Clin Cancer Res"},{"key":"3576_CR61","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1161\/CIRCULATIONAHA.120.052318","volume":"144","author":"JC Schupp","year":"2021","unstructured":"Schupp JC, Adams TS, Cosme C, Raredon MSB, Yuan Y, Omote N, et al. Integrated single-cell atlas of endothelial cells of the human lung. Circulation. 2021;144:286\u2013302. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.052318.","journal-title":"Circulation"},{"key":"3576_CR62","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-024-03832-y","volume":"15","author":"Z Li","year":"2024","unstructured":"Li Z, Wu W, Li Q, Heng X, Zhang W, Zhu Y, et al. Bcl6B-dependent suppression of ETV2 hampers endothelial cell differentiation. Stem Cell Res Ther. 2024;15:226. https:\/\/doi.org\/10.1186\/s13287-024-03832-y.","journal-title":"Stem Cell Res Ther"},{"key":"3576_CR63","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.ijrobp.2021.11.019","volume":"112","author":"MA Benadjaoud","year":"2022","unstructured":"Benadjaoud MA, Soysouvanh F, Tarlet G, Paget V, Buard V, Santos de Andrade H, Morilla I, Dos Santos M, Bertho A, l\u2019Homme B, et al. Deciphering the dynamic molecular program of Radiation-Induced endothelial senescence. Int J Radiat Oncol Biol Phys. 2022;112:975\u201385. https:\/\/doi.org\/10.1016\/j.ijrobp.2021.11.019.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"3576_CR64","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1016\/j.cell.2021.04.048","volume":"184","author":"Y Hao","year":"2021","unstructured":"Hao Y, Hao S, Andersen-Nissen E, Mauck WM, Zheng S, Butler A, Lee MJ, Wilk AJ, Darby C, Zager M, et al. Integrated analysis of multimodal single-cell data. Cell. 2021;184:3573\u2013e358729. https:\/\/doi.org\/10.1016\/j.cell.2021.04.048.","journal-title":"Cell"},{"issue":"6","key":"3576_CR65","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20220242","volume":"67","author":"M Bahri","year":"2023","unstructured":"Bahri M, Anstee JE, Opzoomer JW, Arnold JN. Perivascular tumor-associated macrophages and their role in cancer progression. Essays Biochem. 2023;EBC20220242. https:\/\/doi.org\/10.1042\/EBC20220242.","journal-title":"Essays Biochem"},{"key":"3576_CR66","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aaz8836","volume":"7","author":"M Trizzino","year":"2021","unstructured":"Trizzino M, Zucco A, Deliard S, Wang F, Barbieri E, Veglia F, et al. EGR1 is a gatekeeper of inflammatory enhancers in human macrophages. Sci Adv. 2021;7:eaaz8836. https:\/\/doi.org\/10.1126\/sciadv.aaz8836.","journal-title":"Sci Adv"},{"key":"3576_CR67","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00011-016-1017-z","volume":"66","author":"M Srivastava","year":"2017","unstructured":"Srivastava M, Saqib U, Naim A, Roy A, Liu D, Bhatnagar D, et al. The TLR4-NOS1-AP1 signaling axis regulates macrophage polarization. Inflamm Res. 2017;66:323\u201334. https:\/\/doi.org\/10.1007\/s00011-016-1017-z.","journal-title":"Inflamm Res"},{"key":"3576_CR68","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/9512251","volume":"2024","author":"Y Ren","year":"2024","unstructured":"Ren Y, Zhou L, Li X, Zhu X, Zhang Z, Sun X, et al. Taz\/Tead1 promotes alternative macrophage activation and kidney fibrosis via transcriptional upregulation of Smad3. J Immunol Res. 2024;2024:9512251. https:\/\/doi.org\/10.1155\/2024\/9512251.","journal-title":"J Immunol Res"},{"key":"3576_CR69","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1038\/nm1567","volume":"13","author":"J Bernhagen","year":"2007","unstructured":"Bernhagen J, Krohn R, Lue H, Gregory JL, Zernecke A, Koenen RR, et al. MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment. Nat Med. 2007;13:587\u201396. https:\/\/doi.org\/10.1038\/nm1567.","journal-title":"Nat Med"},{"key":"3576_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.labinv.2022.100034","volume":"103","author":"L Cao","year":"2023","unstructured":"Cao L, Wang X, Liu X, Meng W, Guo W, Duan C, et al. Tumor necrosis factor \u03b1-dependent lung inflammation promotes the progression of lung adenocarcinoma originating from alveolar type II cells by upregulating MIF-CD74. Lab Invest. 2023;103:100034. https:\/\/doi.org\/10.1016\/j.labinv.2022.100034.","journal-title":"Lab Invest"},{"key":"3576_CR71","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00034","volume":"5","author":"SN Linch","year":"2015","unstructured":"Linch SN, McNamara MJ, Redmond WL. OX40 agonists and combination immunotherapy: putting the pedal to the metal. Front Oncol. 2015;5:34. https:\/\/doi.org\/10.3389\/fonc.2015.00034.","journal-title":"Front Oncol"},{"key":"3576_CR72","doi-asserted-by":"publisher","first-page":"2160","DOI":"10.4049\/jimmunol.164.4.2160","volume":"164","author":"AD Weinberg","year":"2000","unstructured":"Weinberg AD, Rivera MM, Prell R, Morris A, Ramstad T, Vetto JT, et al. Engagement of the OX-40 receptor in vivo enhances antitumor immunity. J Immunol. 2000;164:2160\u20139. https:\/\/doi.org\/10.4049\/jimmunol.164.4.2160.","journal-title":"J Immunol"},{"key":"3576_CR73","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1084\/jem.183.5.2185","volume":"183","author":"A Imura","year":"1996","unstructured":"Imura A, Hori T, Imada K, Ishikawa T, Tanaka Y, Maeda M, et al. The human OX40\/gp34 system directly mediates adhesion of activated T cells to vascular endothelial cells. J Exp Med. 1996;183:2185\u201395. https:\/\/doi.org\/10.1084\/jem.183.5.2185.","journal-title":"J Exp Med"},{"key":"3576_CR74","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0165-2478(02)00082-2","volume":"84","author":"A Kotani","year":"2002","unstructured":"Kotani A, Hori T, Matsumura Y, Uchiyama T. Signaling of gp34 (OX40 ligand) induces vascular endothelial cells to produce a CC chemokine RANTES\/CCL5. Immunol Lett. 2002;84:1\u20137. https:\/\/doi.org\/10.1016\/s0165-2478(02)00082-2.","journal-title":"Immunol Lett"},{"key":"3576_CR75","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/j.1600-065X.2009.00766.x","volume":"229","author":"M Croft","year":"2009","unstructured":"Croft M, So T, Duan W, Soroosh P. The significance of OX40 and OX40L to T-cell biology and immune disease. Immunol Rev. 2009;229:173\u201391. https:\/\/doi.org\/10.1111\/j.1600-065X.2009.00766.x.","journal-title":"Immunol Rev"},{"key":"3576_CR76","doi-asserted-by":"publisher","first-page":"3007","DOI":"10.4049\/jimmunol.163.6.3007","volume":"163","author":"Y Matsumura","year":"1999","unstructured":"Matsumura Y, Hori T, Kawamata S, Imura A, Uchiyama T. Intracellular signaling of gp34, the OX40 ligand: induction of c-jun and c-fos mRNA expression through gp34 upon binding of its receptor, OX40. J Immunol. 1999;163:3007\u201311.","journal-title":"J Immunol"},{"key":"3576_CR77","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/ni.2065","volume":"12","author":"A Oeckinghaus","year":"2011","unstructured":"Oeckinghaus A, Hayden MS, Ghosh S. Crosstalk in NF-\u03baB signaling pathways. Nat Immunol. 2011;12:695\u2013708. https:\/\/doi.org\/10.1038\/ni.2065.","journal-title":"Nat Immunol"},{"key":"3576_CR78","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.bbrc.2022.01.009","volume":"592","author":"GV Freundt","year":"2022","unstructured":"Freundt GV, von Samson-Himmelstjerna FA, Nitz J-T, Luedde M, Waltenberger J, Wieland T, et al. The orphan receptor GPRC5B activates pro-inflammatory signaling in the vascular wall via Fyn and NF\u03baB. Biochem Biophys Res Commun. 2022;592:60\u20136. https:\/\/doi.org\/10.1016\/j.bbrc.2022.01.009.","journal-title":"Biochem Biophys Res Commun"},{"key":"3576_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/JCI186291","volume":"135","author":"B He","year":"2025","unstructured":"He B, Zhao R, Zhang B, Pan H, Liu J, Huang L, et al. Endothelial OX40 activation facilitates tumor cell escape from T cell surveillance through S1P\/YAP-mediated angiogenesis. J Clin Invest. 2025;135:e186291. https:\/\/doi.org\/10.1172\/JCI186291.","journal-title":"J Clin Invest"},{"key":"3576_CR80","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1042\/CS20150437","volume":"130","author":"E Niccolai","year":"2016","unstructured":"Niccolai E, Taddei A, Ricci F, Rolla S, D\u2019Elios MM, Benagiano M, Bechi P, Bencini L, Ringressi MN, Pini A, et al. Intra-tumoral IFN-\u03b3-producing Th22 cells correlate with TNM staging and the worst outcomes in pancreatic cancer. Clin Sci (Lond). 2016;130:247\u201358. https:\/\/doi.org\/10.1042\/CS20150437.","journal-title":"Clin Sci (Lond)"},{"key":"3576_CR81","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ijc.32715","volume":"146","author":"H Zeng","year":"2020","unstructured":"Zeng H, Liu Z, Wang Z, Zhou Q, Qi Y, Chen Y, et al. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses. Int J Cancer. 2020;146:542\u201352. https:\/\/doi.org\/10.1002\/ijc.32715.","journal-title":"Int J Cancer"},{"key":"3576_CR82","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.1158\/1078-0432.CCR-19-1086","volume":"26","author":"S McCuaig","year":"2020","unstructured":"McCuaig S, Barras D, Mann EH, Friedrich M, Bullers SJ, Janney A, et al. The interleukin 22 pathway interacts with mutant KRAS to promote poor prognosis in colon cancer. Clin Cancer Res. 2020;26:4313\u201325. https:\/\/doi.org\/10.1158\/1078-0432.CCR-19-1086.","journal-title":"Clin Cancer Res"},{"key":"3576_CR83","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50:1317-1334.e10. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.009.","journal-title":"Immunity"},{"key":"3576_CR84","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.it.2022.04.008","volume":"43","author":"R-Y Ma","year":"2022","unstructured":"Ma R-Y, Black A, Qian B-Z. Macrophage diversity in cancer revisited in the era of single-cell omics. Trends Immunol. 2022;43:546\u201363. https:\/\/doi.org\/10.1016\/j.it.2022.04.008.","journal-title":"Trends Immunol"},{"key":"3576_CR85","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41577-022-00737-w","volume":"23","author":"S Goswami","year":"2023","unstructured":"Goswami S, Anandhan S, Raychaudhuri D, Sharma P. Myeloid cell-targeted therapies for solid tumours. Nat Rev Immunol. 2023;23:106\u201320. https:\/\/doi.org\/10.1038\/s41577-022-00737-w.","journal-title":"Nat Rev Immunol"},{"key":"3576_CR86","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1177\/0271678X221101643","volume":"42","author":"M Karam","year":"2022","unstructured":"Karam M, Janbon H, Malkinson G, Brunet I. Heterogeneity and developmental dynamics of LYVE-1 perivascular macrophages distribution in the mouse brain. J Cereb Blood Flow Metab. 2022;42:1797\u2013812. https:\/\/doi.org\/10.1177\/0271678X221101643.","journal-title":"J Cereb Blood Flow Metab"},{"key":"3576_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-023-06021-6","volume":"14","author":"C Xiang","year":"2023","unstructured":"Xiang C, Zhang M, Shang Z, Chen S, Zhao J, Ding B, et al. Single-cell profiling reveals the trajectory of FOLR2-expressing tumor-associated macrophages to regulatory T cells in the progression of lung adenocarcinoma. Cell Death Dis. 2023;14:493. https:\/\/doi.org\/10.1038\/s41419-023-06021-6.","journal-title":"Cell Death Dis"},{"key":"3576_CR88","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1016\/j.cell.2022.02.021","volume":"185","author":"R Nalio Ramos","year":"2022","unstructured":"Nalio Ramos R, Missolo-Koussou Y, Gerber-Ferder Y, Bromley CP, Bugatti M, N\u00fa\u00f1ez NG, Boari T, Richer J, Menger W, Denizeau L, J., et al. Tissue-resident FOLR2\u2009+\u2009macrophages associate with CD8\u2009+\u2009T cell infiltration in human breast cancer. Cell. 2022;185:1189\u2013e120725. https:\/\/doi.org\/10.1016\/j.cell.2022.02.021.","journal-title":"Cell"},{"key":"3576_CR89","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ccell.2016.05.017","volume":"30","author":"CE Lewis","year":"2016","unstructured":"Lewis CE, Harney AS, Pollard JW. The multifaceted role of perivascular macrophages in tumors. Cancer Cell. 2016;30:18\u201325. https:\/\/doi.org\/10.1016\/j.ccell.2016.05.017.","journal-title":"Cancer Cell"},{"key":"3576_CR90","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82531-7","volume":"11","author":"G-L Cai","year":"2021","unstructured":"Cai G-L, Yang Z-X, Guo D-Y, Hu C-B, Yan M-L, Yan J. Macrophages enhance lipopolysaccharide induced apoptosis via Ang1 and NF-\u03baB pathways in human umbilical vein endothelial cells. Sci Rep. 2021;11:2918. https:\/\/doi.org\/10.1038\/s41598-021-82531-7.","journal-title":"Sci Rep"},{"key":"3576_CR91","doi-asserted-by":"publisher","first-page":"213","DOI":"10.33549\/physiolres.934456","volume":"70","author":"Y Fan","year":"2021","unstructured":"Fan Y, Hao Y, Gao D, Li G, Zhang Z. Phenotype and function of macrophage polarization in monocrotaline-induced pulmonary arterial hypertension rat model. Physiol Res. 2021;70:213\u201326. https:\/\/doi.org\/10.33549\/physiolres.934456.","journal-title":"Physiol Res"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03576-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03576-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03576-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T17:02:03Z","timestamp":1768842123000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13046-025-03576-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3576"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03576-4","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"30 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients signed an informed consent for the umbilical cord collection and human umbilical vein endothelial cell isolation. Peripheral blood from healthy volunteers was collected under the Etablissement Fran\u00e7ais du Sang ethics agreement CPDL-PLER-2022 09. Healthy lung biopsies were collected from the BREATHE clinical cohort (NCT0681813) under the ethics agreement 2024-A00509-38.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have agreed with publishing this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}